Oppenheimer lowered the firm’s price target on Community Health (CYH) to $4 from $5 and keeps an Outperform rating on the shares. The firm says the company struggled with volume/acuity trends during Q2, including softer surgical volumes at commercial/Marketplace payors, potentially due to economic or even immigration status concerns. Despite the depressed core earnings, Community Health was able to beat expectations due to the contribution of $75M of DPP not in prior guidance.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CYH:
- Community Health price target lowered to $5 from $6 at RBC Capital
- Community Health Systems Reports Strong Q2 2025 Earnings
- Bill would force hospitals to warn if not equipped to save preemies, WSJ says
- Community Health downgraded to Hold from Buy at Jefferies
- Community Health price target lowered to $3.50 from $4 at Barclays